Rein Therapeutics Inc. (RNTX)

Rein Therapeutics Statistics

Total Valuation

RNTX has a market cap or net worth of $32.39 million. The enterprise value is $26.67 million.

Market Cap	32.39M
Enterprise Value	26.67M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

RNTX has 23.31 million shares outstanding. The number of shares has increased by 137.74% in one year.

Current Share Class	23.31M
Shares Outstanding	23.31M
Shares Change (YoY)	+137.74%
Shares Change (QoQ)	+10.37%
Owned by Insiders (%)	1.04%
Owned by Institutions (%)	15.70%
Float	18.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	10.65
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.86

Current Ratio	0.86
Quick Ratio	0.74
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -79.38% and return on invested capital (ROIC) is -20.42%.

Return on Equity (ROE)	-79.38%
Return on Assets (ROA)	-18.24%
Return on Invested Capital (ROIC)	-20.42%
Return on Capital Employed (ROCE)	-48.91%
Revenue Per Employee	n/a
Profits Per Employee	-$5.38M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.49% in the last 52 weeks. The beta is 1.14, so RNTX's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-57.49%
50-Day Moving Average	1.20
200-Day Moving Average	1.72
Relative Strength Index (RSI)	61.71
Average Volume (20 Days)	252,327

Short Selling Information

The latest short interest is 21,324, so 0.09% of the outstanding shares have been sold short.

Short Interest	21,324
Short Previous Month	27,400
Short % of Shares Out	0.09%
Short % of Float	0.11%
Short Ratio (days to cover)	1.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.35M
Pretax Income	-60.70M
Net Income	-59.15M
EBITDA	-24.35M
EBIT	-24.35M
Earnings Per Share (EPS)	-$2.64

Balance Sheet

The company has $5.72 million in cash and n/a in debt, giving a net cash position of $5.72 million or $0.25 per share.

Cash & Cash Equivalents	5.72M
Total Debt	n/a
Net Cash	5.72M
Net Cash Per Share	$0.25
Equity (Book Value)	48.01M
Book Value Per Share	0.13
Working Capital	-1.09M

Cash Flow

Operating Cash Flow	-21.22M
Capital Expenditures	n/a
Free Cash Flow	-21.22M
FCF Per Share	-$0.91

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-137.74%
Shareholder Yield	-137.74%
Earnings Yield	-182.60%
FCF Yield	-65.52%

Analyst Forecast

The average price target for RNTX is $10.00, which is 619.42% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	619.42%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 11, 2022. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 11, 2022
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1